Source: PR Newswire

Press Release: Institute of Bioengineering and Nanotechnology : Indivumed Announces an International Partnership With IMCB to Establish an Asian-Centric Multiomics Cancer Database for Personalized Oncology

SINGAPORE and HAMBURG, Germany, Dec. 18, 2018 /PRNewswire/ -- Indivumed GmbH today announced the launch of the "Cancer Library Initiative", an operation to further accelerate precision diagnostics and personalised treatment for cancer patients, in collaboration with A*STAR's Institute of...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
Frederick Chew's photo - CEO of Institute of Bioengineering and Nanotechnology

CEO

Frederick Chew

CEO Approval Rating

90/100

Read more